170 related articles for article (PubMed ID: 15153793)
1. Flavonoids such as luteolin, fisetin and apigenin are inhibitors of interleukin-4 and interleukin-13 production by activated human basophils.
Hirano T; Higa S; Arimitsu J; Naka T; Shima Y; Ohshima S; Fujimoto M; Yamadori T; Kawase I; Tanaka T
Int Arch Allergy Immunol; 2004 Jun; 134(2):135-40. PubMed ID: 15153793
[TBL] [Abstract][Full Text] [Related]
2. Luteolin, a flavonoid, inhibits AP-1 activation by basophils.
Hirano T; Higa S; Arimitsu J; Naka T; Ogata A; Shima Y; Fujimoto M; Yamadori T; Ohkawara T; Kuwabara Y; Kawai M; Matsuda H; Yoshikawa M; Maezaki N; Tanaka T; Kawase I; Tanaka T
Biochem Biophys Res Commun; 2006 Feb; 340(1):1-7. PubMed ID: 16343431
[TBL] [Abstract][Full Text] [Related]
3. Flavonoids and related compounds as anti-allergic substances.
Kawai M; Hirano T; Higa S; Arimitsu J; Maruta M; Kuwahara Y; Ohkawara T; Hagihara K; Yamadori T; Shima Y; Ogata A; Kawase I; Tanaka T
Allergol Int; 2007 Jun; 56(2):113-23. PubMed ID: 17384531
[TBL] [Abstract][Full Text] [Related]
4. Luteolin, a flavonoid, inhibits CD40 ligand expression by activated human basophils.
Hirano T; Arimitsu J; Higa S; Naka T; Ogata A; Shima Y; Fujimoto M; Yamadori T; Ohkawara T; Kuwabara Y; Kawai M; Kawase I; Tanaka T
Int Arch Allergy Immunol; 2006; 140(2):150-6. PubMed ID: 16601352
[TBL] [Abstract][Full Text] [Related]
5. Fisetin, a flavonol, inhibits TH2-type cytokine production by activated human basophils.
Higa S; Hirano T; Kotani M; Matsumoto M; Fujita A; Suemura M; Kawase I; Tanaka T
J Allergy Clin Immunol; 2003 Jun; 111(6):1299-306. PubMed ID: 12789233
[TBL] [Abstract][Full Text] [Related]
6. Decreased pro-inflammatory cytokine production by LPS-stimulated PBMC upon in vitro incubation with the flavonoids apigenin, luteolin or chrysin, due to selective elimination of monocytes/macrophages.
Hougee S; Sanders A; Faber J; Graus YM; van den Berg WB; Garssen J; Smit HF; Hoijer MA
Biochem Pharmacol; 2005 Jan; 69(2):241-8. PubMed ID: 15627476
[TBL] [Abstract][Full Text] [Related]
7. IFN-alpha inhibits IL-3 priming of human basophil cytokine secretion but not leukotriene C4 and histamine release.
Chen YH; Bieneman AP; Creticos PS; Chichester KL; Schroeder JT
J Allergy Clin Immunol; 2003 Nov; 112(5):944-50. PubMed ID: 14610485
[TBL] [Abstract][Full Text] [Related]
8. Mercuric chloride enhances immunoglobulin E-dependent mediator release from human basophils.
Strenzke N; Grabbe J; Plath KE; Rohwer J; Wolff HH; Gibbs BF
Toxicol Appl Pharmacol; 2001 Aug; 174(3):257-63. PubMed ID: 11485386
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-16 inhibits immunoglobulin e production by B lymphocytes.
Trudelle A; El Bassam S; Pinsonneault S; Mazer B; Laberge S
Int Arch Allergy Immunol; 2007; 143(2):109-18. PubMed ID: 17228167
[TBL] [Abstract][Full Text] [Related]
10. Tryptanthrin inhibits Th2 development, and IgE-mediated degranulation and IL-4 production by rat basophilic leukemia RBL-2H3 cells.
Iwaki K; Ohashi E; Arai N; Kohno K; Ushio S; Taniguchi M; Fukuda S
J Ethnopharmacol; 2011 Mar; 134(2):450-9. PubMed ID: 21216280
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine.
Schroeder JT; Schleimer RP; Lichtenstein LM; Kreutner W
Clin Exp Allergy; 2001 Sep; 31(9):1369-77. PubMed ID: 11591186
[TBL] [Abstract][Full Text] [Related]
12. Structural requirements of flavonoids for inhibition of antigen-Induced degranulation, TNF-alpha and IL-4 production from RBL-2H3 cells.
Mastuda H; Morikawa T; Ueda K; Managi H; Yoshikawa M
Bioorg Med Chem; 2002 Oct; 10(10):3123-8. PubMed ID: 12150856
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory activity of structurally related flavonoids, Apigenin, Luteolin and Fisetin.
Funakoshi-Tago M; Nakamura K; Tago K; Mashino T; Kasahara T
Int Immunopharmacol; 2011 Sep; 11(9):1150-9. PubMed ID: 21443976
[TBL] [Abstract][Full Text] [Related]
14. Mite antigen-induced IL-4 and IL-13 production by basophils derived from atopic asthma patients.
Shimizu Y; Shichijo M; Hiramatsu K; Takeuchi M; Nagai H; Takagi K
Clin Exp Allergy; 1998 Apr; 28(4):497-503. PubMed ID: 9641578
[TBL] [Abstract][Full Text] [Related]
15. Nerve growth factor or IL-3 induces more IL-13 production from basophils of allergic subjects than from basophils of nonallergic subjects.
Sin AZ; Roche EM; Togias A; Lichtenstein LM; Schroeder JT
J Allergy Clin Immunol; 2001 Sep; 108(3):387-93. PubMed ID: 11544458
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment with low levels of FcεRI-crosslinking stimulation enhances basophil mediator release.
Koketsu R; Yamaguchi M; Suzukawa M; Tanaka Y; Tashimo H; Arai H; Nagase H; Matsumoto K; Saito H; Ra C; Yamamoto K; Ohta K
Int Arch Allergy Immunol; 2013; 161 Suppl 2():23-31. PubMed ID: 23711850
[TBL] [Abstract][Full Text] [Related]
17. IL-13 released by and localized in human basophils.
Li H; Sim TC; Alam R
J Immunol; 1996 Jun; 156(12):4833-8. PubMed ID: 8648131
[TBL] [Abstract][Full Text] [Related]
18. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
[TBL] [Abstract][Full Text] [Related]
19. Effects of phosphodiesterase inhibitors on interleukin-4 and interleukin-13 generation from human basophils.
Eskandari N; Wickramasinghe T; Peachell PT
Br J Pharmacol; 2004 Aug; 142(8):1265-72. PubMed ID: 15265810
[TBL] [Abstract][Full Text] [Related]
20. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
